Scientists have used advanced technology to ‘micro-dissect’ the first brain cells to perish in Alzheimer’s disease. The result is a short list of genes that could represent new drug targets.
Scientists have used advanced technology to ‘micro-dissect’ the first brain cells to perish in Alzheimer’s disease. The result is a short list of genes that could represent new drug targets.